Unlock the full potential of DBS therapy

Replacing your battery

If you already have DBS therapy, you might notice a reduction in the effectiveness of your DBS treatment over time. The fact is batteries do not last forever and need to be replaced when they outlive their life cycle or effectiveness. The good news is battery replacement is not complicated and is done as an out-patient procedure. The leads in your brain remain intact; only the battery in your chest will be replaced.

Switch to Boston Scientific

If you’re a DBS patient with another system and it’s time to replace your battery, you may be able to switch to a Boston Scientific battery. Boston Scientific batteries (also referred to as stimulators or IPGs) are compatible with many systems.

Life after the switch

DBS patient Matt Eagles shares his story on the impact of switching to a Boston Scientific battery.

What doctors are saying

Dr Richard Bucholz talks about the importance of the right battery in DBS therapy.

Reasons to make the switch

1. Battery longevity

The DBS battery that gives you confidence in reliable technology.

2. Convenient recharging

With a simple remote while you relax.

3. Comfort¹

This small DBS device is designed with smooth and gently rounded edges for comfort.

4. Image Guided Programming

84% of patients experienced quality of life improvements after being reprogrammed using Image Guided Programming.²

5. Optimised therapy

Multiple Independent Current Control (MICC) technology shapes the stimulation to your needs, providing stable therapy.^3,4,5

6. Personalised therapy

Advanced programming to deliver therapy with precision

Learn more about DBS

Download our patient brochure

Download

Elderly woman in the living room searches for DBS clinic on the internet with her laptop

Where can I find the closest Deep Brain Stimulation clinic?

With our clinic finder, you can locate the nearest DBS centre.

Find a DBS clinic

This material is for informational Purposes only and not meant for medical diagnosis. This information does not constitute medical or legal advice, and Boston Scientific makes no representation regarding the medical benefits included in this information. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.

1. April 2020 – Footprint defined as volume + thickness. Data on file. at Boston Scientific Corporation.

2. Torres V, 2024, npj Parkinson’s Disease. https://doi.org/10.1038/s41531-024-00639-9.

3. Bronstein JM, et al. 2014. DOI: 10.1111/ner.12227.

4. Timmermann et al. 2015, Lancet Neurol 2015; 14: 693–701.

5. Lempka et al. 2010. Clin Neurophysiol. 2010 December ; 121(12): 2128–2133. doi:10.1016/j.clinph.2010.04.026.

Compared to all EU commercially available DBS IPG's from 2010 onwards.Intrepid Study : Vitek JL, Jain R, Chen L, et al. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson’s disease (INTREPID): a multicenter, double-blind, randomised, sham-controlled study. Lancet Neurology. 2020;19(6):491‐501. doi:10.1016/S1474-4422(20)30108-3
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.